1. Home
  2. LEXX vs NTZ Comparison

LEXX vs NTZ Comparison

Compare LEXX & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • NTZ
  • Stock Information
  • Founded
  • LEXX 2004
  • NTZ 1959
  • Country
  • LEXX Canada
  • NTZ Italy
  • Employees
  • LEXX 7
  • NTZ N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • LEXX Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • LEXX 38.9M
  • NTZ 45.4M
  • IPO Year
  • LEXX N/A
  • NTZ 1993
  • Fundamental
  • Price
  • LEXX $2.23
  • NTZ $4.10
  • Analyst Decision
  • LEXX Strong Buy
  • NTZ
  • Analyst Count
  • LEXX 2
  • NTZ 0
  • Target Price
  • LEXX $11.00
  • NTZ N/A
  • AVG Volume (30 Days)
  • LEXX 202.4K
  • NTZ 6.3K
  • Earning Date
  • LEXX 01-10-2025
  • NTZ 12-12-2024
  • Dividend Yield
  • LEXX N/A
  • NTZ N/A
  • EPS Growth
  • LEXX N/A
  • NTZ N/A
  • EPS
  • LEXX N/A
  • NTZ N/A
  • Revenue
  • LEXX $464,278.00
  • NTZ $365,846,531.00
  • Revenue This Year
  • LEXX $20.39
  • NTZ N/A
  • Revenue Next Year
  • LEXX $113.25
  • NTZ N/A
  • P/E Ratio
  • LEXX N/A
  • NTZ N/A
  • Revenue Growth
  • LEXX 105.24
  • NTZ N/A
  • 52 Week Low
  • LEXX $1.20
  • NTZ $3.80
  • 52 Week High
  • LEXX $6.85
  • NTZ $7.12
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.23
  • NTZ 41.43
  • Support Level
  • LEXX $2.00
  • NTZ $4.04
  • Resistance Level
  • LEXX $2.54
  • NTZ $4.45
  • Average True Range (ATR)
  • LEXX 0.24
  • NTZ 0.39
  • MACD
  • LEXX -0.00
  • NTZ -0.08
  • Stochastic Oscillator
  • LEXX 27.06
  • NTZ 10.33

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.

Share on Social Networks: